John Pestian

John Pestian

Dr. Pestian’s research focuses on developing advanced technology for the care of neuropsychiatric illness. Using artificial intelligence, his team integrates analyses of trait and state characteristics for early identification of both neurological and psychiatric illness. His lab developed and implemented an automated, electronic health record surveillance system that processes clinician notes to identify epilepsy surgery candidates up to two years earlier than traditional approaches. The lab also focuses on earlier identification of individuals at risk of suicide, depression, and bipolar and anxiety disorders using verbal and nonverbal language. His current projects include fusion of linguistic, acoustic, and visual cues that are being tested in selected Cincinnati Public Schools and Cincinnati Children’s clinics. Dr. Pestian and his lab have 18 issued patents and he is active in the entrepreneurial community. This activity has yielded over 500 jobs and one-half billion in revenue have been created. One invention, Processing Text With Domain- Specific Spreading Activation Methods, is a platform for neuropsychiatric research. Another, Optimization and Individualization of Medication Selection and Dosing, has been used for optimal mental health drug selection on more than 420,000 people. He and his colleagues have published more than 80 peer reviewed publications that focus on applied and translational sciences apropos to artificial intelligence.


Contributions

Login

New Here? Sign Up

Looking for increased exposure in the field of biomedical engineering? EMBS offers journals, conferences and a community for biomedical engineers. Membership includes PULSE Magazine.

Join EMBS